XOMA Reports Fourth Quarter and Full Year 2018 Financial Results and Operating Highlights
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Wall St falls as oil ticks up, yields rise ahead of US-China summit
- BTIG’s Krinsky warns 2000-like signals are mounting
- HSBC remains max bullish on stocks, tells investors to lean into tech
- Analyst explains why the midterm outcome is a “fundamental non-event”
- Oil holds near two-week lows while diesel cracks hit record
XOMA (XOMA) Tops Q4 EPS by 14c, Revenues Beat
March 7, 2019 7:19 AM ESTXOMA (NASDAQ: XOMA) reported Q4 EPS of ($0.35), $0.14 better than the analyst estimate of ($0.49). Revenue for the quarter came in at $1.55 million versus the consensus estimate of $1.13 million.
In 2018, we completed the first transaction under our royalty-aggregator business model, adding seven assets being developed by Merck and Incyte, bringing our royalty... More
